James River Announces Third Quarter 2026 Results
Reserve additions weighed on operating results even as administrative expenses declined and investment income increased.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
James River (NASDAQ: JRVR) reported a third-quarter 2026 net loss available to common shareholders of $189.4 million, driven by goodwill impairment. The loss was $4.08 per diluted share, versus $0.02 a year earlier. The $181.8 million non-cash impairment does not affect adjusted net operating results, statutory capital or debt-covenant compliance.
Adjusted net operating results swung to a $4.4 million loss from $17.4 million of income. Excess and Surplus Lines recorded $19.2 million of adverse reserve development, primarily tied to a Product Liability portfolio in runoff; Specialty Admitted recorded $1.4 million. Gross written premiums fell 22% to $186.1 million. General and administrative expenses declined 9% year over year, while net investment income rose 1% to $22.2 million. Tangible common equity fell 10.5% from year-end to $367.8 million. The board declared a $0.01 quarterly dividend.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointGeneral and administrative expenses declined 9% year over year in both the quarter and year to date.
- Moderate pointRecent E&S accident years beginning in 2023 showed lower claim frequency and incurred losses.
- Minor pointNet investment income rose 1% year over year to $22.2 million and over 9% sequentially.
- Minor pointE&S submissions for active divisions increased 8% from the prior-year quarter.
- Minor pointAnnualized gross investment yield reached 4.7%, versus 4.6% in the prior-year quarter.
- Minor pointThird-quarter interest expense decreased to $5.708 million from $6.224 million a year earlier.
Negative
- Major pointThird-quarter common-shareholder net loss widened to $189.4 million, or $4.08 diluted, from $948,000, or $0.02.
- Moderate pointAdjusted net operating results swung to a $4.445 million loss from $17.383 million income a year earlier.
- Moderate pointE&S adverse reserve development of $19.2 million primarily involved a Product Liability portfolio fully in runoff. 11% of market cap
- Moderate pointE&S gross written premiums declined 19% year over year to $170.404 million.
- Moderate pointE&S net written premiums declined 15% year over year to $104.027 million.
- Moderate pointE&S net earned premiums declined 10% year over year to $126.321 million.
- Moderate pointThird-quarter total revenues decreased to $147.709 million from $172.735 million a year earlier.
- Moderate pointTangible common equity declined 10.5% from December 31, 2025, to $367.8 million.
- Moderate pointAccumulated other comprehensive loss increased $52.0 million during the year as rates rose.
11 minor points
- Minor pointGoodwill impairment of $181.8 million was non-cash, without affecting statutory capital or debt-covenant compliance.
- Minor pointSpecialty Admitted adverse reserve development totaled $1.4 million in the third quarter.
- Minor pointSpecialty Admitted gross written premiums declined 43% year over year to $15.700 million.
- Minor pointSpecialty Admitted net written premiums declined 4% year over year to $983,000.
- Minor pointSpecialty Admitted net earned premiums declined 83% year over year to $1.390 million.
- Minor pointNet realized and unrealized investment losses were $2.857 million, versus $1.239 million gains a year earlier.
- Minor pointCasualty lines continued to face heightened competition.
- Minor pointShareholders’ equity fell to $291.9 million from $538.2 million at December 31, 2025, predominantly reflecting goodwill impairment.
- Minor pointTangible common equity per share fell to $7.95 from $8.94 at December 31, 2025.
- Minor pointNine-month common-shareholder results swung to a $195.871 million loss from $9.447 million income a year earlier.
- Minor pointNine-month adjusted net operating income declined to $11.385 million from $38.178 million a year earlier.
Details
Market move: JRVR -11.04% vs previous close. 3Q26 earnings report
On Nov 9, the day this news came out, the latest delayed price for JRVR is 11.04% below the previous close. Our momentum scanner has recorded 2 alerts for this stock so far that day. The latest delayed price is $3.35.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Goodwill impairment
- $181.8 million
- Third quarter 2026; non-cash
- Net loss available to common shareholders
- $189.4 million
- Third quarter 2026
- Diluted loss per share
- $4.08
- Third quarter 2026
- Adjusted net operating loss
- $4.4 million
- Third quarter 2026
- Adjusted net operating loss per diluted share
- $0.10
- Third quarter 2026
- E&S net adverse reserve development
- $19.2 million
- Third quarter 2026
- Gross written premiums
- $186.1 million, down 22%
- Third quarter 2026 versus prior-year quarter
- Cash dividend per common share
- $0.01
- Declared for third quarter 2026
Previous Earnings Reports
-
Reported $17.4 million adjusted operating income and $2.6 million favorable reserve development.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
goodwill impairment financial
adverse reserve development financial
retroactive reinsurance financial
loss portfolio transfer financial
anti-dilutive financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHAPEL HILL, N.C., Nov. 09, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today reported the following results for the third quarter of 2026 as compared to the same period in 2025. Third quarter results included a non-cash goodwill impairment of
| Three Months Ended September 30, | Three Months Ended September 30, | ||||||||||||||
| ($ in thousands, except for share data) | 2026 | per diluted share | 2025 | per diluted share | |||||||||||
| Net loss from continuing operations available to common shareholders | $ | (189,276 | ) | $ | (4.08 | ) | $ | (376 | ) | $ | (0.01 | ) | |||
| Net loss from discontinued operations1 | (133 | ) | $ | — | (572 | ) | $ | (0.01 | ) | ||||||
| Net loss available to common shareholders | (189,409 | ) | $ | (4.08 | ) | (948 | ) | $ | (0.02 | ) | |||||
| Adjusted net operating (loss) income2 | (4,445 | ) | $ | (0.10 | ) | 17,383 | $ | 0.32 | |||||||
Unless specified otherwise, all underwriting performance ratios presented herein are for our continuing operations and business not subject to retroactive reinsurance accounting.
Third Quarter 2026 Overview:
- Adjusted net operating loss2 of
$4.4 million or$0.10 per diluted share, was primarily impacted by adverse reserve development in the Excess & Surplus ("E&S") segment. - E&S new and renewal submission growth for active divisions continues to be strong, increasing
8% compared to the prior year quarter, reflecting a strong market opportunity, while heightened competition remains across casualty lines. The Company has remained disciplined in adding risk that aligns with its underwriting standards, choosing to focus on growth in smaller accounts. - Annually, during the third quarter, the Company completes its Detailed Valuation Review of the E&S segment's reserves. This is a first principles, ground-up review of all assumptions underpinning the reserve base. Following that review this year, the Company recognized net adverse development of
$19.2 million on total E&S net reserves of$1.0 billion . The development was driven by a specific portfolio, which is fully in runoff, within the Product Liability line. Notably, the Company continues to observe much lower frequency and reduced incurred loss dynamics across the entire E&S portfolio from the more recent accident years beginning in 2023. - The Company continues to deliver expense reductions. General and administrative expenses declined by
9% for both the quarter and on a year-to-date basis compared to prior year periods. On a year-to-date basis, expenses for Specialty Admitted declined40% and expenses for the Corporate Segment declined15% . - Net investment income of
$22.2 million grew by over9% sequentially compared to the second quarter ($20.3 million ) and by1% compared to the prior year quarter ($21.9 million ) driven by attractive book yields in fixed maturities as well as strong income from private investments.
Frank D'Orazio, the Company’s Chief Executive Officer, commented, "E&S submission growth and our market opportunity set remain strong across the franchise as we leverage our investments in technology and further emphasize smaller accounts and greater profitability. During the quarter, we completed our first principles reserve review and while the Company continues to see distinct improvement in overall profitability since 2023, we bolstered reserves in our Product Liability line to address a specific portfolio that is now fully in runoff."
Third Quarter 2026 Operating Results
- Gross written premium of
$186.1 million , consisting of the following:
| Three Months Ended September 30, | |||||||||
| ($ in thousands) | 2026 | 2025 | % Change | ||||||
| Excess and Surplus Lines | $ | 170,404 | $ | 209,831 | (19)% | ||||
| Specialty Admitted Insurance | 15,700 | 27,445 | (43)% | ||||||
| $ | 186,104 | $ | 237,276 | (22)% | |||||
- Net written premium of
$105.0 million , consisting of the following:
| Three Months Ended September 30, | |||||||||
| ($ in thousands) | 2026 | 2025 | % Change | ||||||
| Excess and Surplus Lines | $ | 104,027 | $ | 121,707 | (15)% | ||||
| Specialty Admitted Insurance | 983 | 1,026 | (4)% | ||||||
| $ | 105,010 | $ | 122,733 | (14)% | |||||
- Net earned premium of
$127.7 million , consisting of the following:
| Three Months Ended September 30, | |||||||||
| ($ in thousands) | 2026 | 2025 | % Change | ||||||
| Excess and Surplus Lines | $ | 126,321 | $ | 140,175 | (10)% | ||||
| Specialty Admitted Insurance | 1,390 | 8,276 | (83)% | ||||||
| $ | 127,711 | $ | 148,451 | (14)% | |||||
- Pre-tax net (adverse) favorable reserve development by segment on business not subject to retroactive reinsurance accounting was as follows:
| Three Months Ended September 30, | |||||||
| ($ in thousands) | 2026 | 2025 | |||||
| Excess and Surplus Lines | $ | (19,170 | ) | $ | 2,369 | ||
| Specialty Admitted Insurance | (1,446 | ) | 236 | ||||
| $ | (20,616 | ) | $ | 2,605 | |||
- The third quarter of 2026 included
$19.2 million of net adverse reserve development in the E&S segment and$1.4 million of net adverse reserve development within Specialty Admitted. The reserve additions for E&S were informed by the Company's annual Detailed Valuation Review process that took place during the quarter. The adverse development within E&S related primarily to the Product Liability line, and the portfolio that has driven this development is in runoff. The Company continues to observe lower frequency and incurred losses in its more recent accident years following the significant underwriting changes made to its portfolio since 2023, and will continue to monitor these trends to inform estimates. - In the third quarter of 2026, the Company continued to deliver meaningful reductions in general and administrative expenses. These decreased by
9% compared to the prior year quarter, notably in the Specialty Admitted (down34% ) and Corporate (down21% ) segments.
Investment Results
Net investment income for the third quarter of 2026 was
The Company’s net investment income consisted of the following:
| Three Months Ended September 30, | ||||||||||
| ($ in thousands) | 2026 | 2025 | % Change | |||||||
| Total Net Investment Income | $ | 22,185 | $ | 21,919 | 1 | % | ||||
| Private Investments | 2,190 | 1,066 | 105 | % | ||||||
| All Other Investments | 19,995 | 20,853 | (4 | )% | ||||||
The Company’s annualized gross investment yield on average fixed maturity, bank loan and equity securities for the three months ended September 30, 2026 was
Net realized and unrealized losses of
Capital Management
The Company announced that its Board of Directors declared a cash dividend of
Tangible Common Equity
Shareholders' equity of
Conference Call
James River will hold a conference call to discuss its third quarter results tomorrow, November 10, 2026 at 8:30 a.m. Eastern Time. Investors may access the conference call by dialing (800) 715-9871, Conference ID 6057866, or via the investor website at https://investors.jrvrgroup.com and clicking on the “Investor Relations” link. A webcast replay of the call will be available by visiting the company website.
Forward-Looking Statements
This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. In some cases, such forward-looking statements may be identified by terms such as believe, expect, seek, may, will, should, intend, project, anticipate, plan, estimate, guidance or similar words. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Although it is not possible to identify all of these risks and uncertainties, they include, among others, the following: the inherent uncertainty of estimating loss and loss adjustment expense reserves and the possibility that incurred losses and loss adjustment expenses may be greater than our estimate used to compute loss and loss adjustment expense reserves included in the financial statements; inaccurate estimates and judgments in our risk management may expose us to greater risks than intended; downgrades in the financial strength rating or outlook of our regulated insurance subsidiaries impacting our competitive position and ability to attract and retain insurance business that our subsidiaries write and ultimately our financial condition and triggering a default on our credit facility; the potential loss of key members of our management team or key employees, and our ability to attract and retain personnel; adverse economic and competitive factors resulting in the sale of fewer policies than expected or an increase in the frequency or severity of claims, or both; risks associated with strategic transactions and initiatives, including our ability to identify, negotiate, consummate and realize the anticipated benefits of acquisitions, dispositions, investments, joint ventures, reinsurance transactions, capital-raising transactions and other strategic alternatives; the impact of a higher than expected inflationary environment on our reserves, loss adjustment expenses, the values of our investments and investment returns, and our compensation expenses; exposure to credit risk, interest rate risk and other market risk in our investment portfolio and our reinsurers; reliance on a select group of brokers and agents for a significant portion of our business and the impact of our potential failure to maintain such relationships; reliance on a select group of customers for a significant portion of our business and the impact of our potential failure to maintain, or decision to terminate, such relationships; our ability to obtain insurance and reinsurance coverage at prices and on terms that allow us to transfer risk, adequately protect our Company against financial loss and that supports our growth plans; losses resulting from reinsurance counterparties failing to pay us on reinsurance claims, insurance companies with whom we have a fronting arrangement failing to pay us for claims, or a former customer with whom we have an indemnification arrangement failing to perform its reimbursement obligations, and our potential inability to demand or maintain adequate collateral to mitigate such risks; the inherent uncertainty of estimating reinsurance recoverable on unpaid losses and the possibility that reinsurance may be less than our estimate of reinsurance recoverable on unpaid losses; inadequacy of premiums we charge to compensate us for our losses incurred; an impairment of our intangible assets affecting our results of operations and book value; changes in laws or government regulation, including tax or insurance laws and regulations; changes in U.S. tax laws (including associated regulations) and the interpretation of certain provisions applicable to insurance/reinsurance businesses with U.S. and non-U.S. operations, which may be retroactive and could have a significant effect on us including, among other things, by potentially increasing our tax rate, as well as on our shareholders; a failure of any of the loss limitations or exclusions we utilize in our insurance products to shield us from unanticipated financial losses or legal exposures, or other liabilities; losses from catastrophic events, such as natural disasters and terrorist acts, which substantially exceed our expectations and/or exceed the amount of reinsurance we have purchased to protect us from such events; potential effects on our business of emerging claim and coverage issues; the potential impact of internal or external fraud, operational errors, systems malfunctions or cyber security incidents; our ability to manage our growth effectively; failure to maintain effective internal controls in accordance with the Sarbanes-Oxley Act of 2002, as amended; changes in our financial condition, regulations or other factors that may restrict our subsidiaries’ ability to pay us dividends; an adverse result in any litigation or legal proceedings we are or may become subject to; and inability to generate taxable income and execute tax planning strategies which could adversely impact our ability to recognize deferred tax assets at the level reflected on our balance sheet. Additional information about these risks and uncertainties, as well as others that may cause actual results to differ materially from those in the forward-looking statements, is contained in our filings with the U.S. Securities and Exchange Commission, including our most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q. These forward-looking statements speak only as of the date of this release and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.
Non-GAAP Financial Measures
In presenting James River Group Holdings, Inc.’s results, management has included financial measures that are not calculated under standards or rules that comprise accounting principles generally accepted in the United States (“GAAP”). Such measures, including underwriting (loss) profit, adjusted net operating (loss) income, tangible equity, tangible common equity, and adjusted net operating return on tangible common equity (which is calculated as annualized adjusted net operating income expressed as a percentage of the average quarterly tangible common equity balances in the respective period), are referred to as non-GAAP measures. These non-GAAP measures may be defined or calculated differently by other companies. These measures should not be viewed as a substitute for those measures determined in accordance with GAAP. Reconciliations of such measures to the most comparable GAAP figures are included at the end of this press release.
About James River Group Holdings, Inc.
James River Group Holdings, Inc. is a holding company that owns and operates a group of specialty insurance companies. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance. Each of the Company’s regulated insurance subsidiaries is rated “A-” (Excellent) by A.M. Best Company.
Visit James River Group Holdings, Inc. on the web at https://jrvrgroup.com.
For more information contact:
Bob Zimardo
SVP, Investments and Investor Relations
InvestorRelations@james-river-group.com
| James River Group Holdings, Inc. and Subsidiaries Condensed Consolidated Balance Sheet Data (Unaudited) | |||||||
| ($ in thousands, except for share data) | September 30, 2026 | December 31, 2025 | |||||
| ASSETS | |||||||
| Invested assets: | |||||||
| Fixed maturity securities, available-for-sale, at fair value | $ | 1,374,704 | $ | 1,404,774 | |||
| Equity securities, at fair value | 72,358 | 73,092 | |||||
| Bank loan participations, at fair value | 154,688 | 155,138 | |||||
| Short-term investments | 4,868 | 0 | |||||
| Other invested assets | 71,666 | 64,152 | |||||
| Total invested assets | 1,678,284 | 1,697,156 | |||||
| Cash and cash equivalents | 167,903 | 260,941 | |||||
| Restricted cash equivalents (a) | 8,710 | 8,481 | |||||
| Accrued investment income | 14,252 | 12,744 | |||||
| Premiums receivable and agents’ balances, net | 89,655 | 153,638 | |||||
| Reinsurance recoverable on unpaid losses, net | 1,821,124 | 2,026,110 | |||||
| Reinsurance recoverable on paid losses | 140,165 | 118,243 | |||||
| Deferred policy acquisition costs | 28,870 | 31,286 | |||||
| Goodwill and intangible assets | 31,815 | 213,918 | |||||
| Other assets | 311,858 | 337,413 | |||||
| Total assets | $ | 4,292,636 | $ | 4,859,930 | |||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
| Reserve for losses and loss adjustment expenses | $ | 2,912,382 | $ | 3,099,418 | |||
| Unearned premiums | 374,954 | 447,644 | |||||
| Funds held (a) | 7,485 | 7,485 | |||||
| Deferred reinsurance gain | 107,719 | 86,720 | |||||
| Senior debt | 225,800 | 225,800 | |||||
| Junior subordinated debt | 104,055 | 104,055 | |||||
| Accrued expenses | 25,099 | 31,006 | |||||
| Other liabilities | 110,150 | 186,534 | |||||
| Total liabilities | 3,867,644 | 4,188,662 | |||||
| Series A redeemable preferred shares | 133,115 | 133,115 | |||||
| Total shareholders’ equity | 291,877 | 538,153 | |||||
| Total liabilities, Series A redeemable preferred shares, and shareholders’ equity | $ | 4,292,636 | $ | 4,859,930 | |||
| Tangible equity (b) | $ | 500,896 | $ | 544,070 | |||
| Tangible equity per share (b) | $ | 8.38 | $ | 9.15 | |||
| Tangible common equity per share (b) | $ | 7.95 | $ | 8.94 | |||
| Shareholders' equity per share | $ | 6.31 | $ | 11.71 | |||
| Common shares outstanding | 46,249,038 | 45,968,584 | |||||
| (a) Restricted cash equivalents and the funds held liability includes funds posted by the Company to a trust account for the benefit of a third party administrator handling the claims on the Rasier commercial auto policies in run-off. Such funds held in trust secure the Company's obligations to reimburse the administrator for claims payments, and are primarily sourced from the collateral posted to the Company by Rasier and its affiliates to support their obligations under the indemnity agreements and the loss portfolio transfer reinsurance agreement with the Company. | |||||||
| (b) See “Reconciliation of Non-GAAP Measures” | |||||||
| James River Group Holdings, Inc. and Subsidiaries Condensed Consolidated Income Statement Data (Unaudited) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| ($ in thousands, except for share data) | 2026 | 2025 | 2026 | 2025 | |||||||||||
| REVENUES | |||||||||||||||
| Gross written premiums | $ | 186,104 | $ | 237,276 | $ | 691,376 | $ | 909,640 | |||||||
| Net written premiums (a) | 105,010 | 122,733 | 373,506 | 426,679 | |||||||||||
| Net earned premiums (a) | 127,711 | 148,451 | 402,441 | 452,962 | |||||||||||
| Net investment income | 22,185 | 21,919 | 63,789 | 62,443 | |||||||||||
| Net realized and unrealized (losses) gains on investments | (2,857 | ) | 1,239 | (8,490 | ) | (484 | ) | ||||||||
| Other income | 670 | 1,126 | 2,697 | 4,946 | |||||||||||
| Total revenues | 147,709 | 172,735 | 460,437 | 519,867 | |||||||||||
| EXPENSES | |||||||||||||||
| Losses and loss adjustment expenses (b) | 104,423 | 121,004 | 311,688 | 333,670 | |||||||||||
| Other operating expenses | 43,199 | 42,561 | 138,451 | 140,592 | |||||||||||
| Other expenses | 1,160 | 204 | 2,161 | 1,775 | |||||||||||
| Interest expense | 5,708 | 6,224 | 16,910 | 17,570 | |||||||||||
| Amortization of intangible assets | 90 | 90 | 272 | 272 | |||||||||||
| Impairment of goodwill | 181,831 | — | 181,831 | — | |||||||||||
| Total expenses | 336,411 | 170,083 | 651,313 | 493,879 | |||||||||||
| (Loss) income from continuing operations before income taxes | (188,702 | ) | 2,652 | (190,876 | ) | 25,988 | |||||||||
| Income tax (benefit) expense on continuing operations | (1,395 | ) | 1,059 | (1,415 | ) | 8,287 | |||||||||
| Net (loss) income from continuing operations | (187,307 | ) | 1,593 | (189,461 | ) | 17,701 | |||||||||
| Net loss from discontinued operations | (133 | ) | (572 | ) | (503 | ) | (2,347 | ) | |||||||
| NET (LOSS) INCOME | (187,440 | ) | 1,021 | (189,964 | ) | 15,354 | |||||||||
| Dividends on Series A preferred shares | (1,969 | ) | (1,969 | ) | (5,907 | ) | (5,907 | ) | |||||||
| NET (LOSS) INCOME AVAILABLE TO COMMON SHAREHOLDERS | $ | (189,409 | ) | $ | (948 | ) | $ | (195,871 | ) | $ | 9,447 | ||||
| ADJUSTED NET OPERATING (LOSS) INCOME (c) | $ | (4,445 | ) | $ | 17,383 | $ | 11,385 | $ | 38,178 | ||||||
| (LOSS) INCOME PER COMMON SHARE | |||||||||||||||
| Basic | |||||||||||||||
| Continuing operations | $ | (4.08 | ) | $ | (0.01 | ) | $ | (4.22 | ) | $ | 0.26 | ||||
| Discontinued operations | $ | 0.00 | $ | (0.01 | ) | $ | (0.01 | ) | $ | (0.05 | ) | ||||
| $ | (4.08 | ) | $ | (0.02 | ) | $ | (4.23 | ) | $ | 0.21 | |||||
| Diluted | |||||||||||||||
| Continuing operations | $ | (4.08 | ) | $ | (0.01 | ) | $ | (4.22 | ) | $ | 0.25 | ||||
| Discontinued operations | $ | 0.00 | $ | (0.01 | ) | $ | (0.01 | ) | $ | (0.05 | ) | ||||
| $ | (4.08 | ) | $ | (0.02 | ) | $ | (4.23 | ) | $ | 0.20 | |||||
| ADJUSTED NET OPERATING (LOSS) INCOME PER COMMON SHARE | |||||||||||||||
| Basic | $ | (0.10 | ) | $ | 0.38 | $ | 0.25 | $ | 0.83 | ||||||
| Diluted (d) | $ | (0.10 | ) | $ | 0.32 | $ | 0.24 | $ | 0.73 | ||||||
| Weighted-average common shares outstanding: | |||||||||||||||
| Basic | 46,339,604 | 46,026,399 | 46,254,038 | 45,954,992 | |||||||||||
| Diluted | 46,339,604 | 46,026,399 | 46,254,038 | 46,461,351 | |||||||||||
| Cash dividends declared per common share | $ | 0.01 | $ | 0.01 | $ | 0.03 | $ | 0.03 | |||||||
| Ratios: | |||||||||||||||
| Loss ratio | 81.9 | % | 65.7 | % | 72.2 | % | 66.9 | % | |||||||
| Expense ratio (e) | 33.7 | % | 28.3 | % | 34.4 | % | 30.5 | % | |||||||
| Combined ratio | 115.6 | % | 94.0 | % | 106.6 | % | 97.4 | % | |||||||
| Accident year loss ratio (f) | 65.7 | % | 65.7 | % | 65.8 | % | 65.4 | % | |||||||
| (a) Net written premium and net earned premium were impacted by $— million and | |||||||||||||||
| (b) Losses and loss adjustment expenses include expenses of ( | |||||||||||||||
| (c) See "Reconciliation of Non-GAAP Measures". | |||||||||||||||
| (d) Potential common shares related to RSUs were anti-dilutive in the three months ended September 30, 2026 and excluded from the calculation. RSUs were dilutive and included in the denominator in the calculation for the nine months ended September 30, 2026 as well as the three and nine-month prior year periods. The outstanding Series A preferred shares were anti-dilutive in the current periods and dilutive in the prior year periods. Dividends on the Series A preferred shares were added back to the numerator of the calculations and common shares from an assumed conversion of the Series A preferred shares were included in the denominator in the prior year periods. | |||||||||||||||
| (e) Calculated with a numerator comprising other operating expenses less gross fee income (in specific instances when the Company is not retaining insurance risk) included in “Other income” in our Condensed Consolidated Income Statements of | |||||||||||||||
| (f) Ratio of losses and loss adjustment expenses for the current accident year, excluding development on prior accident year reserves, to net earned premiums for the current year (excluding net earned premium adjustments on certain reinsurance treaties with reinstatement premiums associated with prior years). | |||||||||||||||
| James River Group Holdings, Inc. and Subsidiaries Segment Results | |||||||||||||||||||||
| EXCESS AND SURPLUS LINES | |||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||
| Gross written premiums | $ | 170,404 | $ | 209,831 | (18.8 | )% | $ | 632,859 | $ | 723,518 | (12.5 | )% | |||||||||
| Net written premiums (a) | $ | 104,027 | $ | 121,707 | (14.5 | )% | $ | 370,369 | $ | 403,431 | (8.2 | )% | |||||||||
| Net earned premiums (a) | $ | 126,321 | $ | 140,175 | (9.9 | )% | $ | 395,453 | $ | 418,573 | (5.5 | )% | |||||||||
| Losses and loss adjustment expenses excluding retroactive reinsurance | (101,436 | ) | (89,033 | ) | 13.9 | % | (280,781 | ) | (271,697 | ) | 3.3 | % | |||||||||
| Underwriting expenses | (35,678 | ) | (34,709 | ) | 2.8 | % | (110,880 | ) | (107,078 | ) | 3.6 | % | |||||||||
| Underwriting (loss) profit (b) | $ | (10,793 | ) | $ | 16,433 | — | $ | 3,792 | $ | 39,798 | (90.5 | )% | |||||||||
| Ratios: | |||||||||||||||||||||
| Loss ratio | 80.3 | % | 63.5 | % | 71.0 | % | 64.9 | % | |||||||||||||
| Expense ratio | 28.2 | % | 24.8 | % | 28.0 | % | 25.6 | % | |||||||||||||
| Combined ratio | 108.5 | % | 88.3 | % | 99.0 | % | 90.5 | % | |||||||||||||
| Accident year loss ratio (c) | 65.1 | % | 63.5 | % | 64.9 | % | 63.5 | % | |||||||||||||
| (a) Net written premium and net earned premium were impacted by $— million and | |||||||||||||||||||||
| (b) See "Reconciliation of Non-GAAP Measures". | |||||||||||||||||||||
| (c) Ratio of losses and loss adjustment expenses for the current accident year, excluding development on prior accident year reserves, to net earned premiums for the current year (excluding net earned premium adjustments on certain reinsurance treaties with reinstatement premiums associated with prior years). | |||||||||||||||||||||
| SPECIALTY ADMITTED INSURANCE | |||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | % Change | 2026 | 2025 | % Change | |||||||||||||||
| Gross written premiums | $ | 15,700 | $ | 27,445 | (42.8 | )% | $ | 58,517 | $ | 186,122 | (68.6 | )% | |||||||||
| Net written premiums | $ | 983 | $ | 1,026 | (4.2 | )% | $ | 3,137 | $ | 23,248 | (86.5 | )% | |||||||||
| Net earned premiums | $ | 1,390 | $ | 8,276 | (83.2 | )% | $ | 6,988 | $ | 34,389 | (79.7 | )% | |||||||||
| Losses and loss adjustment expenses | (3,104 | ) | (8,456 | ) | (63.3 | )% | (9,908 | ) | (31,147 | ) | (68.2 | )% | |||||||||
| Underwriting expenses | (1,767 | ) | (172 | ) | 927.3 | % | (5,163 | ) | (5,321 | ) | (3.0 | )% | |||||||||
| Underwriting loss (a), (b) | $ | (3,481 | ) | $ | (352 | ) | 888.9 | % | $ | (8,083 | ) | $ | (2,079 | ) | 288.8 | % | |||||
| (a) See "Reconciliation of Non-GAAP Measures". | |||||||||||||||||||||
| (b) Underwriting results for the three and nine months ended September 30, 2026 include gross fee income of | |||||||||||||||||||||
Underwriting Performance Ratios
The following table provides the underwriting performance ratios of the Company's continuing operations inclusive of the business subject to retroactive reinsurance accounting. There is no economic impact to the Company over the life of a retroactive reinsurance contract so long as any additional losses subject to the contract are within the limit of the contract and the counterparty performs under the contract. Retroactive reinsurance accounting is not indicative of our current and ongoing operations. Management believes that providing loss ratios and combined ratios on business not subject to retroactive reinsurance accounting gives the users of our financial statements useful information in evaluating our current and ongoing operations.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||
| Excess and Surplus Lines: | |||||||||||
| Loss Ratio | 80.3 | % | 63.5 | % | 71.0 | % | 64.9 | % | |||
| Impact of retroactive reinsurance | (0.1 | )% | 16.8 | % | 5.3 | % | 7.4 | % | |||
| Loss Ratio including impact of retroactive reinsurance | 80.2 | % | 80.3 | % | 76.3 | % | 72.3 | % | |||
| Combined Ratio | 108.5 | % | 88.3 | % | 99.0 | % | 90.5 | % | |||
| Impact of retroactive reinsurance | (0.1 | )% | 16.8 | % | 5.3 | % | 7.4 | % | |||
| Combined Ratio including impact of retroactive reinsurance | 108.4 | % | 105.1 | % | 104.3 | % | 97.9 | % | |||
| Consolidated: | |||||||||||
| Loss Ratio | 81.9 | % | 65.7 | % | 72.2 | % | 66.9 | % | |||
| Impact of retroactive reinsurance | (0.1 | )% | 15.8 | % | 5.2 | % | 6.8 | % | |||
| Loss Ratio including impact of retroactive reinsurance | 81.8 | % | 81.5 | % | 77.4 | % | 73.7 | % | |||
| Combined Ratio | 115.6 | % | 94.0 | % | 106.6 | % | 97.4 | % | |||
| Impact of retroactive reinsurance | (0.1 | )% | 15.8 | % | 5.2 | % | 6.8 | % | |||
| Combined Ratio including impact of retroactive reinsurance | 115.5 | % | 109.8 | % | 111.8 | % | 104.2 | % | |||
RECONCILIATION OF NON-GAAP MEASURES
Underwriting (Loss) Profit
The following table reconciles the underwriting profit by individual operating segment and for the entire Company to consolidated income from continuing operations before taxes. We believe that the disclosure of underwriting profit by individual segment and of the Company as a whole is useful to investors, analysts, rating agencies and other users of our financial information in evaluating our performance because our objective is to consistently earn underwriting profits. We evaluate the performance of our segments and allocate resources based primarily on underwriting profit. We define underwriting profit as net earned premiums and gross fee income (in specific instances when the Company is not retaining insurance risk) less losses and loss adjustment expenses on business from continuing operations not subject to retroactive reinsurance accounting and other operating expenses. Other operating expenses include the underwriting, acquisition, and insurance expenses of the operating segments and, for consolidated underwriting profit, the expenses of the Corporate and Other segment. Our definition of underwriting profit may not be comparable to that of other companies.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||
| Underwriting (loss) profit of the operating segments: | |||||||||||||||
| Excess and Surplus Lines | $ | (10,793 | ) | $ | 16,433 | $ | 3,792 | $ | 39,798 | ||||||
| Specialty Admitted Insurance | (3,481 | ) | (352 | ) | (8,083 | ) | (2,079 | ) | |||||||
| Total underwriting (loss) profit of operating segments | (14,274 | ) | 16,081 | (4,291 | ) | 37,719 | |||||||||
| Other operating expenses of the Corporate and Other segment | (5,712 | ) | (7,227 | ) | (22,242 | ) | (26,080 | ) | |||||||
| Underwriting (loss) profit (a) | (19,986 | ) | 8,854 | (26,533 | ) | 11,639 | |||||||||
| Losses and loss adjustment expenses - retroactive reinsurance | 117 | (23,515 | ) | (20,999 | ) | (30,826 | ) | ||||||||
| Net investment income | 22,185 | 21,919 | 63,789 | 62,443 | |||||||||||
| Net realized and unrealized (losses) gains on investments | (2,857 | ) | 1,239 | (8,490 | ) | (484 | ) | ||||||||
| Other income | (532 | ) | 469 | 370 | 1,058 | ||||||||||
| Interest expense | (5,708 | ) | (6,224 | ) | (16,910 | ) | (17,570 | ) | |||||||
| Amortization of intangible assets | (90 | ) | (90 | ) | (272 | ) | (272 | ) | |||||||
| Impairment of goodwill | (181,831 | ) | — | (181,831 | ) | — | |||||||||
| (Loss) income from continuing operations before taxes | $ | (188,702 | ) | $ | 2,652 | $ | (190,876 | ) | $ | 25,988 | |||||
| (a) Included in underwriting results for the three and nine months ended September 30, 2026 is gross fee income of | |||||||||||||||
Adjusted Net Operating Income
We define adjusted net operating income as income available to common shareholders excluding a) income (loss) from discontinued operations, b) the impact of retroactive reinsurance accounting, c) net realized and unrealized gains (losses) on investments, d) impairments of goodwill and intangible assets, e) certain non-operating expenses such as professional service fees related to certain lawsuits, various strategic initiatives, and the filing of registration statements for the offering of securities, f) severance costs associated with terminated employees, and g) deemed dividends recorded with the amendment of the Series A Preferred Shares. Adjusted net operating income should not be viewed as a substitute for net income calculated in accordance with GAAP, and our definition of adjusted net operating income may not be comparable to that of other companies.
Our income available to common shareholders reconciles to our adjusted net operating income as follows:
| Three Months Ended September 30, | |||||||||||||||
| 2026 | 2025 | ||||||||||||||
| Loss Before Taxes | Net Loss | Income Before Taxes | Net (Loss) Income | ||||||||||||
| ($ in thousands) | |||||||||||||||
| (Loss) income available to common shareholders | $ | (190,840 | ) | $ | (189,409 | ) | $ | 111 | $ | (948 | ) | ||||
| Loss from discontinued operations | 169 | 133 | 572 | 572 | |||||||||||
| Losses and loss adjustment expenses - retroactive reinsurance | (117 | ) | (173 | ) | 23,515 | 18,577 | |||||||||
| Net realized and unrealized investment losses (gains) | 2,857 | 2,257 | (1,239 | ) | (979 | ) | |||||||||
| Other expenses | 1,160 | 916 | 189 | 161 | |||||||||||
| Impairment of goodwill | 181,831 | 181,831 | — | — | |||||||||||
| Adjusted net operating (loss) income | $ | (4,940 | ) | $ | (4,445 | ) | $ | 23,148 | $ | 17,383 | |||||
| Nine Months Ended September 30, | |||||||||||||||
| 2026 | 2025 | ||||||||||||||
| (Loss) Income Before Taxes | Net (Loss) Income | Income Before Taxes | Net Income | ||||||||||||
| ($ in thousands) | |||||||||||||||
| (Loss) income available to common shareholders | $ | (197,420 | ) | $ | (195,871 | ) | $ | 17,734 | $ | 9,447 | |||||
| Loss from discontinued operations | 637 | 503 | 2,347 | 2,347 | |||||||||||
| Losses and loss adjustment expenses - retroactive reinsurance | 20,999 | 16,508 | 30,826 | 24,353 | |||||||||||
| Net realized and unrealized investment losses | 8,490 | 6,707 | 484 | 382 | |||||||||||
| Other expenses | 2,161 | 1,707 | 1,760 | 1,649 | |||||||||||
| Impairment of goodwill | 181,831 | 181,831 | — | — | |||||||||||
| Adjusted net operating income | $ | 16,698 | $ | 11,385 | $ | 53,151 | $ | 38,178 | |||||||
Tangible Equity (per Share) and Tangible Common Equity (per Share)
We define tangible equity as shareholders' equity plus mezzanine Series A Preferred Shares and the deferred retroactive reinsurance gain less goodwill and intangible assets, net of amortization. Tangible equity per share represents tangible equity divided by the sum of total shares of common stock outstanding plus the shares of common stock resulting from an assumed conversion of the outstanding Series A Preferred Shares into common stock (at the conversion price effective as of the last day of the applicable period). We define tangible common equity as tangible equity less mezzanine Series A Preferred Shares and tangible common equity per share represents tangible common equity divided by the total shares of common stock outstanding. Our definitions of tangible equity, tangible equity per share, tangible common equity and tangible common equity per share may not be comparable to those of other companies, and they should not be viewed as a substitute for shareholders' equity and shareholders' equity per share calculated in accordance with GAAP. We use tangible equity and tangible common equity internally to evaluate the strength of our balance sheet and to compare returns relative to this measure. The following table reconciles shareholders’ equity to tangible equity and tangible common equity for September 30, 2026, June 30, 2026, December 31, 2025, and September 30, 2025.
| September 30, 2026 | June 30, 2026 | December 31, 2025 | September 30, 2025 | ||||||||||||
| ($ in thousands, except for share data) | |||||||||||||||
| Shareholders' equity (a) | $ | 291,877 | $ | 522,601 | $ | 538,153 | $ | 503,638 | |||||||
| Plus: Series A redeemable preferred shares | 133,115 | 133,115 | 133,115 | 133,115 | |||||||||||
| Plus: Deferred reinsurance gain | 107,719 | 107,836 | 86,720 | 88,796 | |||||||||||
| Less: Goodwill and intangible assets | 31,815 | 213,736 | 213,918 | 214,009 | |||||||||||
| Tangible equity | $ | 500,896 | $ | 549,816 | $ | 544,070 | $ | 511,540 | |||||||
| Less: Series A redeemable preferred shares | 133,115 | 133,115 | 133,115 | 133,115 | |||||||||||
| Tangible common equity | $ | 367,781 | $ | 416,701 | $ | 410,955 | $ | 378,425 | |||||||
| Common shares outstanding | 46,249,038 | 46,239,030 | 45,968,584 | 45,936,898 | |||||||||||
| Common shares from assumed conversion of Series A preferred shares | 13,521,634 | 13,521,634 | 13,521,634 | 13,521,634 | |||||||||||
| Common shares outstanding after assumed conversion of Series A preferred shares | 59,770,672 | 59,760,664 | 59,490,218 | 59,458,532 | |||||||||||
| Equity per share: | |||||||||||||||
| Shareholders' equity (a) | $ | 6.31 | $ | 11.30 | $ | 11.71 | $ | 10.96 | |||||||
| Tangible equity | $ | 8.38 | $ | 9.20 | $ | 9.15 | $ | 8.60 | |||||||
| Tangible common equity | $ | 7.95 | $ | 9.01 | $ | 8.94 | $ | 8.24 | |||||||
| (a) During the third quarter of 2026, the Company performed a quantitative goodwill impairment assessment on the James River Excess & Surplus Lines reporting unit due to the continuation of the sustained decline in the Company's stock price and due to market conditions for excess and surplus lines impacting the reporting unit's actual and projected results. Based on this quantitative testing, the Company determined that the full amount of the goodwill, | |||||||||||||||
________________________________
1 The Company closed the sale of JRG Reinsurance Company Ltd. on April 16, 2024. As a result, the full financials for our former Casualty Reinsurance segment have been classified as discontinued operations for all periods.
2 Adjusted net operating (loss) income is a non-GAAP financial measure and excludes the impact of
3 Tangible common equity is a non-GAAP financial measure. See “Non-GAAP Financial Measures” and “Reconciliation of Non-GAAP Measures” at the end of this press release.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did James River report a loss in the third quarter of 2026?
James River’s $189.4 million net loss available to common shareholders included a $181.8 million non-cash goodwill impairment. Adjusted net operating results also turned negative, primarily affected by adverse reserve development in Excess and Surplus Lines.
Does James River’s goodwill impairment affect statutory capital or debt covenants?
The $181.8 million goodwill impairment does not affect statutory capital, compliance with debt covenants or adjusted net operating results. The goodwill originated when an investor group acquired James River in 2007, rather than from an acquisition made by James River.
When will James River pay its declared quarterly dividend?
James River will pay its $0.01 per common share cash dividend on December 31, 2026, to shareholders of record as of December 15, 2026.